Melbye, Mads
Det Sundhedsvidenskabelige Fakultet,
Denmark
2025 Rank: 78928
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2390 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78928 | 86408 |
| Total Cites | 2497 | 2807 |
| H-index | 22 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 11 | 11 |
| Number of Single+First+Last Authored Papers | 304 | 304 |
| Total Cites to Single+First+Last Authored Papers | 598 | 620 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2174 | 2387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
11.04%
|
|
Melbye, Mads
Norges Teknisk-Naturvitenskapelige Universitet,
Norway
2024 Rank: 75829
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2489 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75829 | 79317 |
| Total Cites | 2636 | 3065 |
| H-index | 23 | 26 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 16 | 16 |
| Number of Single+First+Last Authored Papers | 303 | 303 |
| Total Cites to Single+First+Last Authored Papers | 638 | 654 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2283 | 2532 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.21 |
| Self-Citation Percentage |
14.00%
|
|
Melbye, Mads
Københavns Universitet,
Denmark
2023 Rank: 70418
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2552 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70418 | 74839 |
| Total Cites | 2783 | 3223 |
| H-index | 24 | 26 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 20 | 20 |
| Number of Single+First+Last Authored Papers | 301 | 301 |
| Total Cites to Single+First+Last Authored Papers | 672 | 690 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2386 | 2658 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.21 |
| Self-Citation Percentage |
13.65%
|
|
Melbye, Mads
Københavns Universitet,
Denmark
2022 Rank: 81083
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 3076 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81083 | 85515 |
| Total Cites | 2148 | 2451 |
| H-index | 20 | 21 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 16 | 16 |
| Number of Single+First+Last Authored Papers | 296 | 296 |
| Total Cites to Single+First+Last Authored Papers | 677 | 700 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1917 | 2111 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.16 |
| Self-Citation Percentage |
12.36%
|
|
Melbye, Mads
Statens Serum Institut,
Denmark
2021 Rank: 83350
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 921 out of 224174 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83350 | 85711 |
| Total Cites | 3150 | 3677 |
| H-index | 24 | 25 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 25 | 26 |
| Number of Single+First+Last Authored Papers | 294 | 294 |
| Total Cites to Single+First+Last Authored Papers | 1035 | 1082 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2788 | 3113 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
14.33%
|
|
Melbye, Mads
Statens Serum Institut,
Denmark
2020 Rank: 57173
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1999 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57173 | 56406 |
| Total Cites | 3139 | 3949 |
| H-index | 24 | 26 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 28 | 29 |
| Number of Single+First+Last Authored Papers | 288 | 288 |
| Total Cites to Single+First+Last Authored Papers | 884 | 942 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2653 | 3123 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.26 |
| Self-Citation Percentage |
20.51%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.